Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 16 million infections and more than 600,000 deaths worldwide. There is an urgent need to develop a safe and effective vaccine against SARS-CoV-2. Currently, several strategies are being pursued to...
Main Authors: | Edris Shirvani, Siba K. Samal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/9/8/619 |
Similar Items
-
Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
by: Shin-Hee Kim, et al.
Published: (2019-03-01) -
Cloning of fusion protein gene of Newcastle disease virus into a baculovirus derived bacmid shuttle vector, in order to express it in insect cell line
by: Hashemzadeh MS, et al.
Published: (2015-05-01) -
Newcastle disease in white Pekin ducks: response to experimental vaccination and challenge
by: M Nishizawa, et al.
Published: (2007-06-01) -
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
by: Weina Sun, et al.
Published: (2020-12-01) -
Multi-epitope peptide vaccine prediction against Newcastle disease virus using immuno-informatics approaches
by: N. Putri, et al.
Published: (2021-03-01)